Jiajun Huang Selected Research

Thiophenes

2/2018

APTM, a Thiophene Heterocyclic Compound, Inhibits Human Colon Cancer HCT116 Cell Proliferation Through p53-Dependent Induction of Apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiajun Huang Research Topics

Disease

8	Neoplasms (Cancer) 01/2023 - 01/2016
3	Hypertrophy 07/2019 - 12/2018
2	Atrial Fibrillation 01/2024 - 01/2023
2	Ischemic Stroke 12/2023 - 01/2023
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2023 - 01/2023
2	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2016
1	Anterior Cruciate Ligament Injuries 10/2023
1	Respiratory Insufficiency (Respiratory Failure) 05/2023
1	Cerebral Infarction 05/2023
1	Hemorrhage 05/2023
1	Diabetic Foot 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Atherosclerosis 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Diabetes Mellitus 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2023
1	Residual Neoplasm 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Carcinogenesis 12/2021
1	Postmenopausal Osteoporosis 07/2021
1	Atrophic Gastritis 01/2021
1	Gastritis 01/2021
1	Intervertebral Disc Degeneration 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Multiple Myeloma 01/2020
1	Plasmacytoma 01/2020
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 07/2019
1	Lactic Acidosis 07/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2019
1	Insulin Resistance 12/2018
1	Wounds and Injuries (Trauma) 12/2018
1	Colonic Neoplasms (Colon Cancer) 02/2018

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2018
4	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2016
4	Messenger RNA (mRNA)IBA 01/2019 - 01/2016
3	naringeninIBA 07/2019 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2023 - 09/2022
2	Therapeutic UsesIBA 01/2023 - 07/2019
2	EnzymesIBA 09/2022 - 01/2021
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 07/2019
2	Atrial Natriuretic Factor (ANF)IBA 01/2019 - 12/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024
1	HydrogelsIBA 12/2023
1	Hyaluronic Acid (Hyaluronan)IBA 12/2023
1	Ketamine FDA LinkGeneric 05/2023
1	Xylazine (Xylazin)IBA 05/2023
1	Isoflurane FDA LinkGeneric 05/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	gastrodinIBA 01/2023
1	buyang huanwuIBA 01/2023
1	ApolipoproteinsIBA 01/2023
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2023
1	InterferonsIBA 09/2022
1	AntibodiesIBA 09/2022
1	xanthurenic acidIBA 09/2022
1	KynurenineIBA 09/2022
1	Kynurenic Acid (Kynurenate)IBA 09/2022
1	icariside IIBA 09/2022
1	Angiogenesis InhibitorsIBA 07/2022
1	Fluorouracil (Carac)FDA LinkGeneric 07/2022
1	apatinibIBA 07/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	compound 30IBA 01/2022
1	7-azaindole dimerIBA 01/2022
1	Type 4 Fibroblast Growth Factor ReceptorIBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 12/2021
1	delta-1-pyrroline-5-carboxylateIBA 12/2021
1	MicroRNAs (MicroRNA)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	liujunziIBA 01/2021
1	shikoninIBA 01/2021
1	Competitive Endogenous RNAIBA 01/2021
1	TitaniumIBA 01/2020
1	Hydroxyeicosatetraenoic Acids (HETE)IBA 07/2019
1	Indicators and Reagents (Reagents)IBA 07/2019
1	LipidsIBA 07/2019
1	Phosphopyruvate Hydratase (Enolase)IBA 07/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2019
1	AcidsIBA 01/2019
1	propenylphosphonic acidIBA 01/2019
1	14,15-epoxy-5,8,11-eicosatrienoic acidIBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 12/2018
1	Insulin (Novolin)FDA Link 12/2018
1	CollagenIBA 12/2018
1	CholesterolIBA 12/2018
1	3- amino- 5- ((2,6- dimethylphenyl)amino)- 4- (phenylsulfonyl)- 2- thienyl)(4- fluorophenyl)methanone)IBA 02/2018
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 02/2018
1	ThiophenesIBA 02/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2017
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023 - 01/2016
2	Immunotherapy 01/2023 - 09/2022
1	Transplantation 10/2023
1	Anesthesia 05/2023
1	Radiofrequency Ablation 01/2023
1	Complementary Therapies (Alternative Medicine) 01/2021
1	Radiotherapy 01/2020